← All stocks

Milestone Pharmaceuticals Inc.

MIST Net buying
CIK 0001408443 #4195 in the set updated 21 Sep 2026
Bought (120 mo)
$51.38M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$22.90M
$180.37K on a plan · $159.11K straight out of an exercise
Sold at will
$22.56M
9 of 17 sales
Net
+$28.47M
+$28.81M against sales at will

By person

16 insiders · 51 transactions
1.5×

Joseph Oliveto holds only 1.5 times base salary in stock. $1.01M of shares against $649.64K in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph Oliveto last reported holding, valued at $2.26, the price Common Shares was last bought or sold at on the open market here, on 16 Apr 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
RTW INVESTMENTS, LP entity
10% owner
$36.52M (14)
$13.56M (1)
+$22.96M
7,571,204
$17.11M
+75.5%
BDC CAPITAL INC. entity
10% owner
$3.00M (1)
+$3.00M
2,388,088
$5.40M
+9.1%
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC
10% owner
$6.50M (1)
$4.32M (2)
+$2.18M
2,254,920
$5.10M
+2,552%
Novo Holdings A/S entity
10% owner
$5.00M (1)
$3.84M (1)
+$1.16M
2,434,470
$5.50M
Oliveto Joseph
President and CEO
$555.68K (5)
−$555.68K
446,244
$1.01M
+63.4%
Hasija Amit
CFO & EVP of Corp. Development
$158.21K (2)
−$158.21K
99,848
$225.66K
Nelson Jeffrey Edward
Chief Operating Officer
$158.21K (2)
−$158.21K
49,848
$112.66K
Muller Lorenz
Chief Commercial Officer
$145.85K (2)
−$145.85K
205,406
$464.22K
+314.0%
Bharucha David
Chief Medical Officer
$47.41K (2)
$158.21K (2)
−$110.80K
113,181
$255.79K
TOMSICEK MICHAEL JOHN
Director
$79.80K (1)
+$79.80K
15,000
$33.90K
Wills Robert James
Director
$73.95K (1)
+$73.95K
65,000
$146.90K
Liebert Debra K.
Director
$73.94K (2)
+$73.94K
20,793
$46.99K
Pasternak Richard C
Director
$52.00K (1)
+$52.00K
10,000
$22.60K
TRUEX PAUL F
Director
$28.00K (1)
+$28.00K
81,780
$184.82K
PAPA JOSEPH C
Director
100,000
$226.00K
Douville Philippe
Chief Scientific Officer
43,392
$98.07K
+10.5%

No percentages here. This company's share count has moved by a factor of 2.3 over the window, from 53,327,908 to 124,497,980 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Oliveto Joseph
16 Apr 2026
President and CEO
Sold on a plan
36,500
$2.26
$82.49K
Oliveto Joseph
8 Jan 2026
President and CEO
Sold on a plan
43,000
$2.25
$96.75K
Oliveto Joseph
7 Jan 2026
President and CEO
Sold on a plan
500
$2.25
$1.13K

What was left out

Form 4 filings counted 127
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 5
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 9,914,269
Sales filed before the plan box existed 4
History held since 9 May 2019